🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 156 of 200 · A–Z by INN

  1. ranibizumab

    LUCENTIS Novartis Pharmaceuticals

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    S01LA04

  2. ranibizumab-eqrn

    CIMERLI

    INJECTION FDA: approved

  3. ranibizumab-leyk

    NUFYMCO

    FDA: approved

  4. ranibizumab-nuna

    BYOOVIZ

    INJECTION FDA: approved

  5. ranibizuman

    NMPA: clinical trials

  6. ranitidine

    APO-RANITIDINE Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

  7. ranitidine bismuth citrate

    TRITEC

    ORAL FDA: approved

  8. ranitidine hydrochloride

    RANITIDINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  9. ranolazine

    RANEXA (PREVIOUSLY LATIXA) Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: approved

    C01EB18

  10. rapacuronium bromide

    RAPLON

    INJECTION FDA: approved

  11. ras

    NMPA: clinical trials

  12. rasagiline

    ALZIRAS Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved · NMPA: clinical trials

    N04BD02

  13. rasagiline mesylate

    RASAGILINE MESYLATE Teva Pharma GmbH

    ORAL FDA: approved

  14. rasburicase

    FASTURTEC

    INTRAVENOUS FDA: approved · EMA: approved · PMDA: approved

    V03AF07

  15. rauwolfia serpentina root

    RAUWOLFIA SERPENTINA Teva Pharma GmbH

    ORAL FDA: approved

  16. ravulizumab

    ULTOMIRIS Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    L04AA43

  17. ravulizumab-cwvz

    ULTOMIRIS

    INJECTION FDA: approved

  18. raxibacumab

    RAXIBACUMAB

    IV (INFUSION) FDA: approved

  19. rbd7022

    NMPA: clinical trials

  20. rc18 160 mg

    NMPA: clinical trials

  21. rc48

    NMPA: clinical trials

  22. reboxetine

    EDRONAX Pfizer Australia Pty Ltd

    TGA: approved

  23. recombinant

    NMPA: clinical trials

  24. recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)

    CERVARIX

    PMDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources